Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomen’s Association Rising Star

Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomen’s Association Rising Star

05/03/18

DUBLIN, Ireland, May 03, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP) today announced that Sangita Iyer, director, financial planning and analysis, has been named a 2018 Healthcare Businesswomen's Association (HBA) Rising Star.  Sangita will be honored today at the 29th annual Woman of the Year event in New York.

The HBA is the leading not-for-profit global organization committed to furthering the advancement and impact of women in healthcare worldwide.  Sangita is being recognized for her exemplary leadership, dedication to the healthcare industry, as well as her significant contributions across the company.

“It is an honor to be named a Rising Star by the Healthcare Businesswomen's Association," said Iyer.  “I am constantly working to inspire my team to extend beyond the status quo, tackle new challenges and strive for efficiencies in the way we operate and support business decisions, all with focus to promote growth as employees and future leaders.  I am humbled to be a recipient of this award and I share it with gratitude with my team and the leaders who have shaped my growth.”

Sangita joined Horizon Pharma in March 2015 as senior manager, financial planning and analysis, operations and R&D, and was promoted to her current position in August 2016.  She has taken on assignments of increasing responsibility and leadership at Horizon, including working as the finance lead for implementation of SAP Supply Chain.  Prior to joining Horizon, Sangita spent six years at Fenwal, Inc. where she was manager of financial planning and analysis, responsible for manufacturing and supply chain and rotated roles in supporting research and development, general and administration, as well as commercial.  She started as a senior financial analyst at Transfusion Therapeutics, a division of Baxter, which became Fenwal Inc.  She holds a bachelor's degree in accounting from the University of Mumbai, India, a professional chartered accountants degree from the Institute of Chartered Accountants of India (ICAI) and a master’s degree in finance from University of Texas, San Antonio.

"Sangita has been instrumental in Horizon's successes through her exceptional work within the financial planning and analysis team," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc.  "Sangita's leadership continuously motivates those around her to excel and advance.  On behalf of all of her colleagues, I congratulate Sangita on this tremendous recognition."

About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases.  By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians.  For us, it’s personal: by living up to our own potential, we are helping others live up to theirs.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

Contacts:
U.S. Media Contact:
Geoffrey Curtis
Senior Vice President, Corporate Affairs and Chief Communications Officer
media@horizonpharma.com

Ireland Media Contact:
Ray Gordon
Gordon MRM 
ray@gordonmrm.ie

Primary Logo

Source: Horizon Pharma plc